Abstract
vitamin compounds to the basic dialytic treatment of renal osteodystrophy is of contestable interest. Because 1) optimum conditions of dialysis without D vitamin addition prevent efficiently the progress of severe gyperparathyroidism and osteomalacia 2) the D vitamin compunds could render the phosphatemia control more difficult thus contributing to aggravate the histologic lesions of hyperparathyroidism.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Bone and Bones / pathology
-
Calcifediol
-
Chronic Kidney Disease-Mineral and Bone Disorder / blood
-
Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy*
-
Chronic Kidney Disease-Mineral and Bone Disorder / pathology
-
Drug Therapy, Combination
-
Female
-
Humans
-
Hydroxycholecalciferols / administration & dosage*
-
Kidney Failure, Chronic / therapy
-
Male
-
Middle Aged
-
Parathyroid Hormone / blood
-
Phosphates / blood
-
Renal Dialysis*
Substances
-
Hydroxycholecalciferols
-
Parathyroid Hormone
-
Phosphates
-
Calcifediol
-
alfacalcidol